These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

26 related articles for article (PubMed ID: 15765528)

  • 1. Neuroleptic-induced catalepsy: electrophysiological mechanisms of functional recovery induced by high-frequency stimulation of the subthalamic nucleus.
    Degos B; Deniau JM; Thierry AM; Glowinski J; Pezard L; Maurice N
    J Neurosci; 2005 Aug; 25(33):7687-96. PubMed ID: 16107655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuronal and synaptic adaptations underlying the benefits of deep brain stimulation for Parkinson's disease.
    Xu W; Wang J; Li XN; Liang J; Song L; Wu Y; Liu Z; Sun B; Li WG
    Transl Neurodegener; 2023 Nov; 12(1):55. PubMed ID: 38037124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uncoupling the roles of firing rates and spike bursts in shaping the STN-GPe beta band oscillations.
    Bahuguna J; Sahasranamam A; Kumar A
    PLoS Comput Biol; 2020 Mar; 16(3):e1007748. PubMed ID: 32226014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal Bursting as a Pathophysiological Mechanism in Parkinson's Disease.
    Lobb C
    Basal Ganglia; 2014 Apr; 3(4):187-195. PubMed ID: 24729952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cortical stimulation evokes abnormal responses in the dopamine-depleted rat basal ganglia.
    Kita H; Kita T
    J Neurosci; 2011 Jul; 31(28):10311-22. PubMed ID: 21753008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase relationships support a role for coordinated activity in the indirect pathway in organizing slow oscillations in basal ganglia output after loss of dopamine.
    Walters JR; Hu D; Itoga CA; Parr-Brownlie LC; Bergstrom DA
    Neuroscience; 2007 Jan; 144(2):762-76. PubMed ID: 17112675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The roles of dopamine and serotonin, and of their receptors, in regulating sleep and waking.
    Monti JM; Jantos H
    Prog Brain Res; 2008; 172():625-46. PubMed ID: 18772053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GABAergic control of substantia nigra dopaminergic neurons.
    Tepper JM; Lee CR
    Prog Brain Res; 2007; 160():189-208. PubMed ID: 17499115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrasubthalamic injection of 6-hydroxydopamine induces changes in the firing rate and pattern of subthalamic nucleus neurons in the rat.
    Ni Z; Bouali-Benazzouz R; Gao D; Benabid AL; Benazzouz A
    Synapse; 2001 May; 40(2):145-53. PubMed ID: 11252026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subthalamic nucleus lesions alter basal and dopamine agonist stimulated electrophysiological output from the rat basal ganglia.
    Zahr NM; Martin LP; Waszczak BL
    Synapse; 2004 Nov; 54(2):119-28. PubMed ID: 15352137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multisecond oscillations in the subthalamic nucleus: effects of apomorphine and dopamine cell lesion.
    Allers KA; Kreiss DS; Walters JR
    Synapse; 2000 Oct; 38(1):38-50. PubMed ID: 10941139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unilateral lesion of the pedunculopontine nucleus induces hyperactivity in the subthalamic nucleus and substantia nigra in the rat.
    Breit S; Lessmann L; Benazzouz A; Schulz JB
    Eur J Neurosci; 2005 Nov; 22(9):2283-94. PubMed ID: 16262666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High frequency stimulation of the STN influences the activity of dopamine neurons in the rat.
    Benazzouz A; Gao D; Ni Z; Benabid AL
    Neuroreport; 2000 May; 11(7):1593-6. PubMed ID: 10841382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophysiological alterations in subthalamic neurons after unilateral dopamine depletion in the rat.
    Gajendiran M; Cepeda C; Kha HT; Sison JD; Levine MS
    J Neurosci Res; 2005 Apr; 80(2):203-10. PubMed ID: 15765528
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.